ArticleBMC endocrine disorders2026
Prevalence of food addiction and its association with ghrelin and metabolic parameters in patients with type 1 diabetes mellitus: a cross-sectional study.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThis study aimed to determine the prevalence of food addiction (FA) in adults with type 1 diabetes mellitus (T1DM) and examine its associations with serum ghrelin levels and metabolic control parameters.
methodsThe study included 160 patients with a median age of 32.0 years (range: 19.0-60.0), of whom 51.3% (n = 82) were female. After recording anthropometric measurements, sociodemographic data, medical histories, and detailed physical examinations were obtained. Following an 8-hour fasting period, venous blood samples were collected to measure serum ghrelin levels and biochemical parameters. Serum ghrelin levels were assessed using the ELISA method. FA was evaluated using the modified Yale Food Addiction Scale 2.0 (mYFAS 2.0).
resultsFA prevalence was 25.6% (n = 41). The FA group had higher median BMI (p = 0.047), while monthly income, diabetes duration, and insulin pump use were lower (p = 0.025, p = 0.009, and p = 0.046, respectively). Age, gender, education, and metabolic control indicators (HbA1c, lipids) were similar between groups. Serum ghrelin levels did not differ based on FA status. However, ghrelin showed modest negative correlations with BMI (r=-0.171; p = 0.030), waist circumference (r=-0.256; p = 0.001), and triglycerides (r=-0.168; p = 0.033).
conclusionOur findings indicate that the prevalence of FA is observed at considerable rates among patients with T1DM. Although no significant differences were observed in metabolic control parameters between patients with and without FA, the FA group exhibited a modestly higher BMI, suggesting a potential association between addiction-like eating behavior and adiposity in adults with T1DM. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.